- Home Page
- Latest Updates
- Tumor Types
- Molecular Causes of Cancer
- Biological Pathways
- Therapeutic Targets
- Pipeline Molecules
- Research Education
- Research ADCs
- Research Apoptosis
- Research B cell
- Research BRAF
- Research HDIs
- Research Hedgehog
- Research HER Pathways
- Research VEGF
- Clinical Trials
- Resources
- Contact Us
Research Bcell
Share
Evaluating transformed follicular NHL (fNHL)
- fNHL generally has a long relapsing/remitting disease course, but in some cases can behave aggressively52
- A lymph node or bone marrow biopsy is required to analyze the histology and diagnose transformation to large cell lymphoma.53,54 Morphologic transformation of fNHL into aggressive disease occurs in approximately 25% to 30% of patients during the clinical course of disease55
- In patients with fNHL, the probability of transformation is 22% at 5 years and 31% at 10 years, with a trend toward plateau at 6 years56
- Transformation of follicular lymphoma to an aggressive lymphoma subtype is associated with a fast-moving progressive clinical course, refractoriness to treatment, and short survival25,57
- If transformation is histologically confirmed, the patient is usually treated the same as DLBCL58
- The median overall survival for these patients is typically less than a year56